Particle.news

Download on the App Store

France Confirms Moderate Covid Resurgence as XFG Variant Spreads

Health authorities will begin targeted vaccination for at‑risk groups on 14 October following signs of wider XFG circulation without greater severity.

Overview

  • Public data show rising healthcare use the week of 22–28 September, with 2,628 Covid‑related acts recorded, up 15.7% from the prior week.
  • Emergency visits for suspected Covid among people aged 75 and older increased 24%—about 30 additional visits—according to the Oscour network.
  • SOS Médecins reports stable Covid incidence within acute respiratory consultations, remaining at a moderate activity level.
  • The XFG lineage, a recombinant of LF.7 and LP.8.1.2 now dominant in Europe and the United States, is under WHO monitoring for higher transmissibility without clear evidence of increased severity.
  • ECDC notes growing SARS‑CoV‑2 circulation in Europe with limited hospital impact so far, while France’s autumn‑winter campaign will run from 14 October through January 2026 for older and vulnerable people.